首页> 外文会议>International Conference on "Adjuvant Therapy of Primary Breast Cancer" >Integration of Plastic Surgery in the Course of Breast-Conserving Surgery for Cancer to Improve Cosmetic Results and Radicality of Tumor Excision
【24h】

Integration of Plastic Surgery in the Course of Breast-Conserving Surgery for Cancer to Improve Cosmetic Results and Radicality of Tumor Excision

机译:癌症手术过程中整合癌症术语,提高肿瘤切除的化妆品效果和自由性

获取原文

摘要

Reducing the psychological distress, which may result from the treatment of breast cancer is an important plastic surgical goal. Such distress occurs with both conservative surgery (CS) and total breast reconstruction (BR), as in the case of mastectomy. Immediate or delayed breast reconstructions are becoming increasingly common as their absolute contraindications are becoming less and less. For example, absolute contraindications to immediate breast reconstruction might only be limited to cases of locally advanced disease or inflammatory cancers. Today's plastic surgeons are called upon to improve the cosmetic results of aggressive conservative treatment. Indications for breast-preserving surgery, restricted initially to very small tumors, unifo-cal tumors, are now being proposed for tumors up to 4 or 5 cm in diameter, bifocal tumors located in the same quadrant, and even for large tumors which have been reduced in size by several courses of neoadjuvant chemotherapy. In some cancer protocols, the size reestriction on tumors suitable for CS relates only to tumor size as it compares to total breast volume, the main criterion being the final expected cosmetic result. In all cases, the cosmetic outcome correlates to the size of the specimen removed - more precisely, to the size of the specimen compared to the size of the breast and the size of the tumor including the width of the free margins.
机译:减少了乳腺癌治疗可能导致的心理困扰是一个重要的塑料手术目标。这种痛苦发生在保守的手术(CS)和总乳腺重建(BR)中,如乳房切除术的情况下。随着绝对禁忌症变得越来越少,即时或延迟的乳房重建变得越来越普遍。例如,直接乳腺重建的绝对禁忌症可能仅限于局部晚期疾病或炎症癌症的病例。今天的整形外科医生呼吁改善侵略性保守治疗的美容结果。乳房保存手术的适应症,最初限制为非常小的肿瘤,Unifo-Cal肿瘤,现在正在为直径高达4或5cm的肿瘤,位于同一象限中的双焦肿瘤,甚至用于大型肿瘤通过新辅助化疗的几种课程减少了大小。在一些癌症方案中,适合于Cs的肿瘤的大小reabrisce仅涉及肿瘤大小,因为它比较总乳腺量,主要标准是最终预期的化妆品结果。在所有情况下,化妆品结果与所删除的样本的大小相关 - 更确切地说,与乳房尺寸和肿瘤的大小相比,标本的大小和包括自由边缘的宽度的尺寸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号